Stairlifts Market: Foresees Skyrocketing Growth in the Coming Years Opioid Induced Side Effects Treatment Market

Opioid Induced Side Effects Treatment Market –
Global Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2018-2026
Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and
illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are
available legally on prescription. These drugs interact with opioid receptors on nerve cells in body and
are well known for the management of acute pain and cancer related pain among patients of all age
group.
However, opioid drugs use in noncancerous patients is contentious, mostly related with chronic
pain treatment and the major reason behind it the psychological addiction which may occur due
to the continuous use of opioid drugs also other side efects may induce due to use of opioid
drugs are nausea, sedation, constipation, dizziness, vomiting, sweating, headache, respiratory
depression and physical dependence, among these constipation is the mostly observed problem
occurs in 40% to 95% of patients treated with opioid. Also, some side efects such as delirium
and drowsiness depends on dose and they can be avoided by reducing the amount of dose.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/387
Increase in prevalence of chronic disease and cancer cases with raised use of prescription
based opioids will favor the growth of opioid induced side effects treatment market in the near
future
North America accounts for the major market share of opioid induced side efects treatment
market, as U.S. is the biggest consumer for prescription based opioids. As per NIDA in 2013, out
of the globe U.S. accounted around 100 percent in case of hydrocodone for example – Lortab,
Norco and Vicodin, and 81% for oxycodone for example Endocet and Percocet. Also, as per
American Society of Addiction Medicine (ASAM), drug overdose is the leading cause of death in
U.S. and prescription opioids is the leading factor behind it. In 2015, 12,990 deaths were related
with prescription based pain relievers.
The growth in opioid induced side efects treatment market is expected high in North America
followed by Europe and APAC region. As per the data published by UNODC in 2012, the APAC and
Africa region are the emerging markets for raw opium which could feed to increase opioid